[{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01218386%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02330757%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00195455%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001073","name":"obesity"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02237079%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00431093%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=83d7a440-e904-4e36-afb5-cb02b1c919f7","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"https://api.fda.gov/drug/label.json?search=set_id:5d544453-f6d4-45a4-9ece-2f705b32011f","sourceName":"FDA"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01127295%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01501448%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2cab8dd1-3a10-48e6-86ce-0e5275ed49e5","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0001358","name":"post-traumatic stress disorder"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03371654%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00145522%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT04031885%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"Orphanet_881","name":"Turner syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00837616%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=60f70330-0fac-47fc-b417-5bc1c9451117","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"HP_0100607","name":"dysmenorrhea"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03124524%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=065f33e4-b587-4e66-b896-ca9ab7b7c876","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00537771%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003854","name":"postmenopausal osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1b75458-2e5b-46b9-92c6-fa6daba3770f","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01612871%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00843570%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49860a2f-92f2-4da8-b78f-0efc005d725a","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01489852%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=78f2664f-3de8-4e58-a860-1b5abd6eb7d7","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7fd4976d-720c-40ee-8723-a703645d4ff0","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0002950","name":"pregnancy"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01943812%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02479256%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=723d0427-cf3f-4ad7-8b93-cb1250f345f6","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03120715%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001065","name":"endometriosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01056042%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"Orphanet_64739","name":"Ovarian hyperstimulation syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01500863%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0000764","name":"HIV infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00042289%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003103","name":"urinary tract infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01958073%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001073","name":"obesity"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02237079%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL411","name":"DIETHYLSTILBESTROL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://www.whocc.no/atc_ddd_index/?code=L02AA01","sourceName":"ATC"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0000132","name":"Menorrhagia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=02c91fba-9c47-43ef-ac78-e82369798834","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"HP_0031217","name":"Hot flashes"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00206622%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001271","name":"Atrophic Vaginitis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03493126%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02089854%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00640224%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"https://api.fda.gov/drug/label.json?search=set_id:a6ff9761-7442-4bff-9e50-858c03e27fd0","sourceName":"FDA"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"HP_0000132","name":"Menorrhagia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01165307%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02860897%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa17c22d-32a8-4f48-b7b6-9b8eeeb5a81a","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000536","name":"hyperplasia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02872818%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0009006","name":"hyperandrogenism"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02027337%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"Orphanet_881","name":"Turner syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01518062%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be399623-6400-475d-93d3-1dedd4d43017","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02344940%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7841b848-ba6b-41b8-8c32-fde3eda6e8e6","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01511822%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://www.whocc.no/atc_ddd_index/?code=L02AA03","sourceName":"ATC"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000764","name":"HIV infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02531321%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01822288%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03238703%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8b247e46-203e-4f5b-b5a7-cbd57341c735","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"https://api.fda.gov/drug/label.json?search=set_id:53eff40f-37b1-47b1-a9b8-c22360855f18","sourceName":"FDA"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"https://api.fda.gov/drug/label.json?search=set_id:bd69aa29-1e86-4c1b-9fd3-ba722bc8cd14","sourceName":"FDA"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0004266","name":"primary ovarian insufficiency"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00732693%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003932","name":"bacterial vaginosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01448291%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00224094%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c7de193c-d730-4f63-aa23-178b5f400967","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0009315","name":"thrombophilia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03531437%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0007453","name":"postpartum depression"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02210702%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03355157%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004714","name":"sexual dysfunction"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03018106%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"https://api.fda.gov/drug/label.json?search=set_id:dd15dbd7-75b7-416e-af55-1e90c2bab051","sourceName":"FDA"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=faafb8ce-6955-4de4-8b93-ccc662123b5e","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00593294%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02866786%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0004710","name":"pelvic organ prolapse"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03779633%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004320","name":"suicidal ideation"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03498313%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"https://api.fda.gov/drug/label.json?search=set_id:e762db5b-f7e5-4b62-bee9-30f0322a4bac","sourceName":"FDA"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01553903%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02344940%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03591549%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02436226%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=384e7a40-dcbd-4908-bf5e-65abc9932973","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201477","name":"POLYESTRADIOL PHOSPHATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://www.whocc.no/atc_ddd_index/?code=L02AA02","sourceName":"ATC"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004266","name":"primary ovarian insufficiency"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00837616%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02344888%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01353846%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02575248%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03238703%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01980680%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02479256%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02447328%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01295892%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003854","name":"postmenopausal osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02090400%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02693002%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02352597%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0000765","name":"AIDS"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00829114%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f9d30d9-5553-4cbd-a099-ff045bc85821","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"HP_0100607","name":"dysmenorrhea"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03124524%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1200598","name":"DIETHYLSTILBESTROL DIPHOSPHATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://www.whocc.no/atc_ddd_index/?code=L02AA04","sourceName":"ATC"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/9780702034718"}},{"disease":{"id":"EFO_0003761","name":"unipolar depression"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00030147%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"https://api.fda.gov/drug/label.json?search=set_id:96092977-5514-44a7-be15-51862866c4bf","sourceName":"FDA"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_1000781","name":"overactive bladder"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01613170%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8132454a-6135-4bac-b206-83a55eb8dbc6","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=077bf6ff-afb8-4cb7-9faa-fbb6fd9f037f","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003103","name":"urinary tract infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01958073%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0002950","name":"pregnancy"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00570440%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02860897%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000685","name":"rheumatoid arthritis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02602704%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01765e76-e656-4539-8112-8b7709597c79","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9950303-9322-4f27-9e28-f1cedaf87b20","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003854","name":"postmenopausal osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1b75458-2e5b-46b9-92c6-fa6daba3770f","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02186782%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=843cbef6-cbfb-4a44-bb80-22930753e4c0","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9599335c-4a8f-435d-b96c-27d5e5e34c39","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=63b8c65b-c6fd-44eb-99e5-d6858c871f28","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003854","name":"postmenopausal osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e16705d8-4472-4f83-96ac-69fa2be066cb","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01466673%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0002690","name":"systemic lupus erythematosus"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00392093%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://www.whocc.no/atc_ddd_index/?code=L02BA03","sourceName":"ATC"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003761","name":"unipolar depression"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02255175%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03336437%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c64b8c58-0ef0-4498-a027-2f0a179057b8","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b2f33ee6-0c57-45d9-b8fc-a8daf2a2185c","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03220178%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02186782%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_1001864","name":"uterine prolapse"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02431897%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://www.whocc.no/atc_ddd_index/?code=L02BA02","sourceName":"ATC"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01705249%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00752635%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01174524%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03236740%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02436226%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=69e66f08-be0b-4120-9a30-333b34ad3507","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0009315","name":"thrombophilia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03531437%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02027337%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02344888%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3cb9494c-4d70-4ebd-98ec-0e28021c1fee","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00900744%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003854","name":"postmenopausal osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e16705d8-4472-4f83-96ac-69fa2be066cb","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004714","name":"sexual dysfunction"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2105395","name":"OSPEMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03018106%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8462d6ab-e3cd-4efa-a360-75bf8f917287#nlm34090-1"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02062489%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"Orphanet_881","name":"Turner syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00134745%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://www.whocc.no/atc_ddd_index/?code=L02BA01","sourceName":"ATC"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01752270%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01501448%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b71a2b34-95bf-4430-83a0-1a4d1218ea3c","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01419353%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02690870%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003882","name":"osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00860964%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0007453","name":"postpartum depression"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00744328%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01237535%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03355157%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00185328%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00160173%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbcb4427-7a99-467c-915f-a8b4c90e2832","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b61cdce5-9fb5-4901-a768-4282a684db3f","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00428311%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003854","name":"postmenopausal osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bfdd5d5b-7569-4848-afa2-e820fbe3c8fb","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003854","name":"postmenopausal osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":null,"sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bfdd5d5b-7569-4848-afa2-e820fbe3c8fb","sourceName":"DailyMed"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01353846%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":4,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01529177%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03011684%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001271","name":"Atrophic Vaginitis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00816556%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0000304","name":"breast adenocarcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00005970%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0100607","name":"dysmenorrhea"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00909857%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00075764%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0006861","name":"male breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01638247%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002720%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003857%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003016%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002579%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000249","name":"Alzheimer's disease"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00000177%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00010153%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03351062%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004714","name":"sexual dysfunction"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00413764%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002784%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0031217","name":"Hot flashes"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00272935%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00543127%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02437318%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0100608","name":"metrorrhagia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00293059%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0000186","name":"invasive breast ductal carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01953588%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00295646%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03447132%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00309491%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00160316%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT04060862%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0031217","name":"Hot flashes"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01389102%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00412022%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00905723%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02394496%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001271","name":"Atrophic Vaginitis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02668796%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00651469%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00066703%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001073","name":"obesity"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00687739%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00253422%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003931","name":"bone fracture"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01214291%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00152178%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002755%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1000251","name":"Fallopian Tube Carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02728622%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01758146%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02097459%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"Orphanet_881","name":"Turner syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00191113%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000289","name":"bipolar disorder"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00411203%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02278120%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00036270%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002646%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01610284%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01581814%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02224313%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00006030%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0100607","name":"dysmenorrhea"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00909857%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0004230","name":"endometrial neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00016341%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02251925%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03423199%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002529%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00280657%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002528%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03425838%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00963209%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"Orphanet_881","name":"Turner syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00029159%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00688194%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00929591%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02404051%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003032%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00590785%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00601900%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02995772%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00099437%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1000096","name":"Atrophy"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02770365%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000378","name":"coronary artery disease"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00000529%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0100607","name":"dysmenorrhea"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00569244%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"Orphanet_881","name":"Turner syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01710696%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003418%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000712","name":"stroke"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00026039%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001271","name":"Atrophic Vaginitis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02995694%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01942668%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00072462%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00232661%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003972%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00053898%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002580%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00065325%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0100608","name":"metrorrhagia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00307801%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0002950","name":"pregnancy"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00932321%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00053911%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001271","name":"Atrophic Vaginitis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01400776%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00251082%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0100607","name":"dysmenorrhea"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01129102%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00193726%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000313","name":"carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01357772%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03238092%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02255578%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00256698%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03927456%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001375","name":"Myocardial Ischemia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00000482%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000612","name":"myocardial infarction"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00000482%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002644%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004230","name":"endometrial neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002976%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00267553%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02107703%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00727129%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001271","name":"Atrophic Vaginitis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02195986%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00004205%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000304","name":"breast adenocarcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00310180%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00044291%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03832894%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003678%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00291759%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0000938","name":"osteopenia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00310531%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01633060%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003854","name":"postmenopausal osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL226267","name":"ARZOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00085956%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00849030%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002772%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00893061%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000537","name":"hypertension"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00102141%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002460%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00814125%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00912548%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002707%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002581%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02340221%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00032136%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00793377%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00784862%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00053339%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00545077%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02028507%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003906%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004266","name":"primary ovarian insufficiency"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03568708%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003854","name":"postmenopausal osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL226267","name":"ARZOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00088010%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00034125%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00948402%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003013%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00286117%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00234819%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004215","name":"anorexia nervosa"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01343771%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01622361%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00327769%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00234819%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00541086%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001065","name":"endometriosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01973816%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001100","name":"peritoneal neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02728622%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00390455%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003679%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004215","name":"anorexia nervosa"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01301183%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000378","name":"coronary artery disease"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00000482%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0100607","name":"dysmenorrhea"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02668783%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001375","name":"Myocardial Ischemia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00000529%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02422615%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01579734%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000553","name":"invasive lobular carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01953588%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002864%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0100607","name":"dysmenorrhea"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00196365%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0001065","name":"endometriosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03213457%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00066690%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01300351%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0031217","name":"Hot flashes"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00185237%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0031217","name":"Hot flashes"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00391417%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002542%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02763566%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002777%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001065","name":"endometriosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03343067%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00010140%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00004125%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003882","name":"osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00004650%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00309478%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02344472%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00010322%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0004215","name":"anorexia nervosa"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01343771%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00201851%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0000938","name":"osteopenia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00117260%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0002690","name":"systemic lupus erythematosus"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00000419%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02914158%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00722761%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00629278%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01602380%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000182","name":"hepatocellular carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003424%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00097344%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02344472%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00293540%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02097459%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"Orphanet_3388","name":"Neural tube defect"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00301587%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0001065","name":"endometriosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ENROLLING_BY_INVITATION","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03654274%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00745108%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1000984","name":"inflammatory breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00016276%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001075","name":"ovarian carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02728622%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"SUSPENDED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02137837%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002582%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00193726%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00047099%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001271","name":"Atrophic Vaginitis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01779947%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL226267","name":"ARZOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00034125%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0100607","name":"dysmenorrhea"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00212342%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL411","name":"DIETHYLSTILBESTROL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00316927%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02736032%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002529%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0003882","name":"osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00481169%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00605267%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00038467%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0002621","name":"prostate intraepithelial neoplasia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00106691%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02947685%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003885","name":"multiple sclerosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00127075%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003680%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0100607","name":"dysmenorrhea"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00212277%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_1001271","name":"Atrophic Vaginitis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03294538%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002967%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03351062%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_1001271","name":"Atrophic Vaginitis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03332303%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003882","name":"osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00205777%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"Orphanet_98896","name":"Duchenne muscular dystrophy"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03354039%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01674140%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00233610%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003854","name":"postmenopausal osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL226267","name":"ARZOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00383422%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03439046%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03229057%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003894","name":"acne"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00656981%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00635713%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00949598%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0100607","name":"dysmenorrhea"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00746096%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000537","name":"hypertension"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00000529%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001366","name":"Mastodynia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00534846%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00066807%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00279448%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001645","name":"coronary heart disease"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00319566%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01942135%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000731","name":"uterine fibroid"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ENROLLING_BY_INVITATION","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03751124%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201467","name":"SYNTHETIC CONJUGATED ESTROGENS, B","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00196378%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":3,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03079011%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03272477%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00134654%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL411","name":"DIETHYLSTILBESTROL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00136526%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00295100%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004215","name":"anorexia nervosa"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00088153%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03941730%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003035%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01989780%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00057941%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01437566%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL68055","name":"ACOLBIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00853996%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02603679%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0005411","name":"schizoaffective disorder"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00206557%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000292","name":"bladder carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02197897%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00068419%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0031217","name":"Hot flashes"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL3545015","name":"RAD1901","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00875420%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha degrader","sourceName":null,"sourceUrl":null}},{"disease":{"id":"Orphanet_145","name":"Hereditary breast and ovarian cancer syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00080756%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"Orphanet_145","name":"Hereditary breast and ovarian cancer syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00253539%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004230","name":"endometrial neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00033358%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00871858%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000326","name":"central nervous system cancer"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00006388%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000326","name":"central nervous system cancer"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00541138%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03264638%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03573648%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1000766","name":"skin atrophy"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01553773%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001075","name":"ovarian carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02584465%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00149604%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00033683%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1000984","name":"inflammatory breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003199%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02668666%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02311933%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02115594%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003761","name":"unipolar depression"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00089414%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01984138%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004714","name":"sexual dysfunction"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2107341","name":"FISPEMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02443090%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0002690","name":"systemic lupus erythematosus"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00417430%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000249","name":"Alzheimer's disease"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00066157%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00454805%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00206492%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00052728%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00229697%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02690480%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004266","name":"primary ovarian insufficiency"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00370019%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL3545017","name":"GTX-758","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01393119%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00210028%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02624973%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03024580%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02269670%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001512","name":"endometrial carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00729586%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT04024436%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00754325%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL3545017","name":"GTX-758","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01615120%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004215","name":"anorexia nervosa"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03875378%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0005232","name":"endometrium adenocarcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03643510%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00272740%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00005908%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003859","name":"uterine neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00006903%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000378","name":"coronary artery disease"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00083824%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03147287%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03584009%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02000193%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00080743%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003882","name":"osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL226267","name":"ARZOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00767299%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002680%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000432","name":"breast ductal carcinoma in situ"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02540330%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201468","name":"ESTROGENS, ESTERIFIED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00131924%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00451555%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003761","name":"unipolar depression"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01126801%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02630693%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00082810%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01831076%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01083641%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000389","name":"cutaneous melanoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00492505%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02132000%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00176644%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003042%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02806544%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1000710","name":"hidradenitis suppurativa"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00722800%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02116803%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL226267","name":"ARZOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00005879%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01233947%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00570258%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00774878%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0006861","name":"male breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003199%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02756364%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00629616%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00290654%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001075","name":"ovarian carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00189358%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03192293%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00096369%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002595%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01142401%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03393845%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02404844%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01194427%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000326","name":"central nervous system cancer"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00108069%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001071","name":"lung carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01556191%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0006890","name":"fibrosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00440349%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02958852%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01160718%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001075","name":"ovarian carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01685255%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004243","name":"carcinoid tumor"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00328497%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201468","name":"ESTROGENS, ESTERIFIED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00141557%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00183963%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00183963%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00305448%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT04129216%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00217464%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03377101%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02668666%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01266213%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00365599%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03322215%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00499083%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1000251","name":"Fallopian Tube Carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00189358%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000313","name":"carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02140437%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0006861","name":"male breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00119262%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01614210%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01670877%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00626106%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03056755%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000673","name":"prostate adenocarcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00476645%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000497","name":"fibromatosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02353429%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02890082%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001366","name":"Mastodynia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2137046","name":"AFIMOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00272714%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"Wikipedia","sourceUrl":"http://en.wikipedia.org/wiki/Afimoxifene"}},{"disease":{"id":"EFO_0000692","name":"schizophrenia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00206557%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02760030%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02806544%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000249","name":"Alzheimer's disease"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00006399%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001100","name":"peritoneal neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL226267","name":"ARZOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003670%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1000781","name":"overactive bladder"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00648310%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02894398%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00626106%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001073","name":"obesity"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1405","name":"ESTRONE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00449254%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0007453","name":"postpartum depression"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00059228%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00738777%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00752986%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001100","name":"peritoneal neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00189358%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000249","name":"Alzheimer's disease"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00018343%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0005411","name":"schizoaffective disorder"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00357006%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02216786%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03879577%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003843","name":"pain"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02801786%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02866955%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00287534%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00775242%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00234403%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00543829%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02955394%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00437359%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0003060","name":"non-small cell lung carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00592007%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01124695%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00167648%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00005768%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02988986%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001073","name":"obesity"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1405","name":"ESTRONE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00449202%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003929","name":"relapsing-remitting multiple sclerosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT04002934%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01196936%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003854","name":"postmenopausal osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00238745%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02072512%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000232","name":"adenoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03715413%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03917082%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00357110%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02964507%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00738777%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0009006","name":"hyperandrogenism"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00004763%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03058939%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001331","name":"Genital neoplasm, female"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03531645%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02549430%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL3545017","name":"GTX-758","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01420861%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00194779%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000326","name":"central nervous system cancer"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00024336%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00534417%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02747004%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02738866%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00586898%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03289039%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003992%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000253","name":"amyotrophic lateral sclerosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01257581%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02845388%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02476786%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000546","name":"injury"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00973674%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004234","name":"erectile dysfunction"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2107341","name":"FISPEMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00415571%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03430466%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02374099%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0006861","name":"male breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00118157%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01771458%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01441947%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL3581693","name":"BRILANESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02569801%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha antagonist","sourceName":"Other","sourceUrl":"http://www.gene.com/medical-professionals/pipeline"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00077168%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001416","name":"cervical adenocarcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02482740%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03555877%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201468","name":"ESTROGENS, ESTERIFIED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00141544%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00007904%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02569801%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02913430%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02675231%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00921115%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00372996%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201468","name":"ESTROGENS, ESTERIFIED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00160342%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0002508","name":"Parkinson's disease"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00234676%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001075","name":"ovarian carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00617188%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL3545017","name":"GTX-758","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01326312%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02137083%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00398489%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03202862%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL3545211","name":"SR16234","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00166543%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000289","name":"bipolar disorder"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00026585%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00405938%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000292","name":"bladder carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00589017%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02630693%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001071","name":"lung carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00100854%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00459810%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02953860%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"MP_0001914","name":"hemorrhage"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00394771%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03024580%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004230","name":"endometrial neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL226267","name":"ARZOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003669%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003821","name":"migraine disorder"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00204074%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01933204%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0003914","name":"atherosclerosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00114517%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00919399%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001075","name":"ovarian carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003865%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00405938%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00728949%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02476786%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00722072%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00146601%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02536742%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03045653%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02913430%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02467673%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02049957%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00313170%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02592083%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00138125%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02491983%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02269670%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1000403","name":"Ocular Melanoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00489944%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02000596%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004234","name":"erectile dysfunction"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2107341","name":"FISPEMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02443090%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01797120%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1000906","name":"dry eye syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03821415%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03241810%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02238808%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00302731%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0100608","name":"metrorrhagia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00344383%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00324259%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0031217","name":"Hot flashes"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL3545015","name":"RAD1901","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02653417%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha degrader","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02395627%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003953%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02632045%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004215","name":"anorexia nervosa"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03172533%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"GO_0007568","name":"aging"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00220454%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001361","name":"pulmonary arterial hypertension"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02911844%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004230","name":"endometrial neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02228681%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00637871%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00020735%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02476786%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1655","name":"TOREMIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02506790%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003050%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03781063%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03182634%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00259090%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003882","name":"osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00320567%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02692755%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000294","name":"bladder tumor"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00710970%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02476786%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004714","name":"sexual dysfunction"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00698035%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"Orphanet_145","name":"Hereditary breast and ovarian cancer syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL226267","name":"ARZOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00253539%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL226267","name":"ARZOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003428%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01528345%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02291913%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03007979%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003914","name":"atherosclerosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00005108%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00012025%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01923298%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01298713%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02860000%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00244998%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03161353%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00570323%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02291913%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00274469%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00585507%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02970682%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1000256","name":"Fibrolamellar Carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01953926%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03219476%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1000645","name":"orthostatic intolerance"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01153581%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02132000%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000692","name":"schizophrenia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00357006%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00661531%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02764541%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00268476%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01220076%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"MP_0001914","name":"hemorrhage"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02903121%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00206414%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02646735%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02970682%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003099%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00423917%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00927511%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00201864%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001663","name":"prostate carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02349386%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03633331%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01300676%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02322853%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000326","name":"central nervous system cancer"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00492687%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02188745%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2137046","name":"AFIMOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00952731%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":"Wikipedia","sourceUrl":"http://en.wikipedia.org/wiki/Afimoxifene"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00002679%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001075","name":"ovarian carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL226267","name":"ARZOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003670%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00093002%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004215","name":"anorexia nervosa"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00310791%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03555877%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000253","name":"amyotrophic lateral sclerosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00214110%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00728949%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00684216%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01560416%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02530424%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"Orphanet_774","name":"Hereditary hemorrhagic telangiectasia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00375622%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00005908%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00570921%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"HP_0100608","name":"metrorrhagia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00320580%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00811369%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03211572%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001512","name":"endometrial carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00334295%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":2,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00952731%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02530411%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":2,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00661531%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004220","name":"chronic hepatitis C virus infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01570244%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00543634%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000764","name":"HIV infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01810315%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00550433%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00009997%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003060","name":"non-small cell lung carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01655225%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02705963%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01339442%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003882","name":"osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03234244%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000637","name":"osteosarcoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00001436%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00479778%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02983071%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00479778%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00630435%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01596010%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00396799%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT04079517%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00328120%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003060","name":"non-small cell lung carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01004419%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02057133%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03280563%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00005886%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000764","name":"HIV infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00357604%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02983604%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL226267","name":"ARZOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00005886%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01344031%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03767335%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02088684%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000311","name":"cancer"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02640755%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00550433%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00396799%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003047","name":"hepatitis C virus infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01063023%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL3581693","name":"BRILANESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02621957%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha antagonist","sourceName":"Other","sourceUrl":"http://www.gene.com/medical-professionals/pipeline"}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00472927%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02586675%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03238196%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000180","name":"HIV-1 infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03837015%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00005822%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03344536%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02936206%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL3581693","name":"BRILANESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01823835%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha antagonist","sourceName":"Other","sourceUrl":"http://www.gene.com/medical-professionals/pipeline"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02333370%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03280563%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001075","name":"ovarian carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03197584%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02936206%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0008560","name":"female infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL2355051","name":"CLOMIPHENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03755037%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000574","name":"lymphoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02392611%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003821","name":"migraine disorder"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02792517%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02260661%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01971515%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0008528","name":"urothelial carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03197571%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004220","name":"chronic hepatitis C virus infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00983957%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000095","name":"chronic lymphocytic leukemia"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03301207%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03556800%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003882","name":"osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03382314%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"Orphanet_586","name":"Cystic fibrosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02144246%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"Orphanet_98896","name":"Duchenne muscular dystrophy"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02835079%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001360","name":"type II diabetes mellitus"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00254800%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00864214%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01597193%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02057133%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02657343%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000764","name":"HIV infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00399685%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003047","name":"hepatitis C virus infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02103569%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000311","name":"cancer"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03557619%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0001360","name":"type II diabetes mellitus"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01508858%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0005952","name":"non-Hodgkins lymphoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01296555%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01477632%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003060","name":"non-small cell lung carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03169738%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001359","name":"type I diabetes mellitus"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01265017%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000311","name":"cancer"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02513849%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03003949%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000545","name":"infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1511","name":"ESTRADIOL VALERATE","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00490308%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"DailyMed","sourceUrl":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02684032%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000181","name":"head and neck squamous cell carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03169764%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03554044%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00706225%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000311","name":"cancer"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01209143%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"Orphanet_145","name":"Hereditary breast and ovarian cancer syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03685331%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02599714%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03854903%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004220","name":"chronic hepatitis C virus infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00749138%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL3545015","name":"RAD1901","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02650817%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha degrader","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0004215","name":"anorexia nervosa"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02792153%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03099174%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02333370%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01992952%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000253","name":"amyotrophic lateral sclerosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02166944%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0006318","name":"breast ductal adenocarcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02983071%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00367536%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000544","name":"infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02533427%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"Orphanet_881","name":"Turner syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00870220%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0001075","name":"ovarian carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00003080%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01597388%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02219789%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00424164%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00455962%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01219699%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01192308%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02384746%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00706225%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000588","name":"mesothelioma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01655225%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0008560","name":"female infertility"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03755037%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00464789%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01293747%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03803761%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001951","name":"colorectal carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03169777%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02285179%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_1001271","name":"Atrophic Vaginitis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00167921%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03006172%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02345772%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000764","name":"HIV infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00044837%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01655225%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000685","name":"rheumatoid arthritis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL691","name":"ETHINYL ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03262740%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":"ISBN","sourceUrl":"http://www.isbnsearch.org/isbn/0443059748"}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"UNKNOWN_STATUS","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01603745%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03939897%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003869","name":"breast neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01194908%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000616","name":"neoplasm"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02093351%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0002687","name":"ischemia reperfusion injury"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03663543%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01194908%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0005952","name":"non-Hodgkins lymphoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01655225%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"TERMINATED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00903006%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003882","name":"osteoporosis"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02349113%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03959891%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02626507%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02448771%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01202591%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000305","name":"breast carcinoma"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":1,"status":"NOT_YET_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03554044%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT00745173%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000311","name":"cancer"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1358","name":"FULVESTRANT","type":"SMALL_MOLECULE","activity":"NEGATIVE_MODULATOR"},"clinicalTrial":{"phase":1,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT01394016%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor antagonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000764","name":"HIV infection"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL83","name":"TAMOXIFEN","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":0,"status":"ACTIVE_NOT_RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03382834%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL46740","name":"BAZEDOXIFENE","type":"SMALL_MOLECULE","activity":"OTHER"},"clinicalTrial":{"phase":0,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02274571%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor modulator","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0000660","name":"polycystic ovary syndrome"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":0,"status":"RECRUITING","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03401047%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0002970","name":"muscular disease"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL135","name":"ESTRADIOL","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":0,"status":"WITHDRAWN","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT03069781%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor alpha agonist","sourceName":null,"sourceUrl":null}},{"disease":{"id":"EFO_0003922","name":"menopause"},"target":{"id":"ENSG00000091831","symbol":"ESR1"},"drug":{"id":"CHEMBL1201649","name":"ESTROGENS, CONJUGATED","type":"SMALL_MOLECULE","activity":"POSITIVE_MODULATOR"},"clinicalTrial":{"phase":0,"status":"COMPLETED","sourceUrl":"https://clinicaltrials.gov/search?id=%22NCT02274571%22","sourceName":"Clinical Trials"},"mechanismOfAction":{"name":"Estrogen receptor agonist","sourceName":null,"sourceUrl":null}}]